Kelsey R Smith
Overview
Explore the profile of Kelsey R Smith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smith K, Shah N, Adamczyk A, Weinstein L, Kelly E
BMC Med Educ
. 2023 Dec;
23(1):986.
PMID: 38129846
Background: Substance use increasingly contributes to early morbidity and mortality, which necessitates greater preparation of the healthcare workforce to mitigate its harm. The purpose of this systematic scoping review is...
2.
Reed M, Smith K, Ciocco F, Hass R, Cox A, Kelly E, et al.
Subst Abuse Treat Prev Policy
. 2023 Jan;
18(1):4.
PMID: 36641478
Background: Medication for opioid use disorder (MOUD) is the gold standard treatment for opioid use disorder. Traditionally, "success" in MOUD treatment is measured in terms of program retention, adherence to...
3.
Cunningham A, Felter J, Smith K, Sifri R, Arenson C, Patel A, et al.
J Am Board Fam Med
. 2023 Jan;
PMID: 36593083
Background: OBJECTIVE: DESIGN, PARTICIPANTS, APPROACH: Fourteen primary care providers and staff completed 1-year follow-up semistructured interviews (approximately 1.5 years into the pandemic) about their workplace demands, control, social support, burnout,...
4.
Zanettini C, Pressly J, Ibarra M, Smith K, Gerak L
Psychopharmacology (Berl)
. 2016 Feb;
233(10):2005-13.
PMID: 26900079
Rationale: Gaboxadol is a selective agonist at γ-aminobutyric acidA (GABAA) receptors that contain α4-δ subunits, and it produces anxiolytic and sedative effects. Although adverse effects preclude its clinical use, its...